探索vismodegib:一个非手术的突破在管理先进的周期性基底细胞癌的管理

Georgios Lavasidis1, Argyrios Tzamalis2, Ioannis Tsinopoulos2

  • 1MSc Ocular Surgery, School of Medicine, Aristotle University of Thessaloniki, University Campus, 54124 Thessaloniki, Greece; Evidence-based Medicine Unit, Department of Hygiene and Epidemiology, School of Medicine, University of Ioannina, University Campus, 45110 Ioannina, Greece; Department of Ophthalmology, Elpis General Hospital of Athens, Dimitsanas 7, 11522 Athens, Greece.

概括

维斯莫德吉布有效地治疗晚期骨干细胞癌 (BCC),显示出良好的反应率和改善生活质量. 需要进一步的随机试验来确认其在管理这一具有挑战性的眼部癌症方面的全部潜力.